CellmatiQ is honored and proud to be again featured in the list of the most promising German AI startups in the category “Health & Pharma”.
CellmatiQ has been ranked as #103 of the global AI-in-healthcare startups list 2020, together with only four other German companies.
CellmatiQ and its AI-based automated Cephalometric Analysis were featured in the December 2019 issue (#6) of the Digital Dental Magazin.
The formal paper by our university partners, which analyzes a subset of the CellmatiQ software and which has won the “Arnold Biber Award” in September 2019, has been published by SpringerLINK.
Quintessence Publishing was so kind to publish a newsletter about the “DentaliQ ortho” production start.
We appreciate the interview by DisruptorDaily, which nicely features CellmatiQ.
Proud to be amongst the initial 52 German companies to commit to the “AI Made in Germany” seal of the German AI Association with the goal to build human-centered and human-beneficial AI.
Jaro Bláha has been interviewed by the NZZ about the challenges of meaningful and safe AI diagnostics in healthcare: NZZ Article (08-Aug-2018)
CellmatiQ has been featured as the Editor’s Pick in the July 2018 issue of AnalyticsInsight ePaper (page 8).
Great to see that Germany is catching up in the AI domain. CellmatiQ is in the “Health & Pharma” box.
NVIDIA, our sponsor in the Inception program, has featured CellmatiQ and our technology in their NVIDIA Blog
CellmatiQ applied for NVIDIA’s Inception Program for start-ups. This morning we received the following response from NVIDIA: “Thank you for your interest in NVIDIA’s Inception program! After careful review, we have determined your startup is a great fit for our program, and will help advance the field of artificial intelligence (AI) in a meaningful way… […]